Ampersand Capital Partners

Skip to content



December 8, 2014

ATS Labs Announces New Name and Introduces New CEO

December 1, 2014

Bioclinica Names Dr. John Hubbard Chief Executive Officer

October 29, 2014

Ampersand Exits Chantest Investment

July 14, 2014

ATS Labs, Inc. Announces the Acquisition of MicroTest Labs, Inc.

July 1, 2014

Ampersand Sells Viracor-IBT to Eurofins for $255 Million

June 10, 2014

Bioventus Announces U.S. Debut of Feature-Rich New EXOGEN® Device

April 30, 2014

NDC Launches New Brand Strategy

February 4, 2014

Bioventus Acquires DUROLANE Assets from Galderma

January 16, 2014

Merger to Create Leading Provider of Specialty Outsourced Clinical Services

January 1, 2014

Shaping the Next Generation of Cardiovascular Devices Through Biomedical Textile Engineering


December 10, 2013

Viracor-IBT Laboratories’ Acquisition of the National Institute of Transplantation

November 13, 2013

PRA Acquires CRI Lifetree

November 13, 2013

Viracor-IBT Laboratories Acquires Assets of the National Institute of Transplantation

September 17, 2013

NDC Appoints Dan Lemaitre to the Board of Directors

July 29, 2013

NDC Appoints Dean Schauer as President and CEO

July 3, 2013

Blue Sky BioServices Expands its Executive Team

July 1, 2013

Bioventus Acquires Exclusive Rights to Pfizer’s BMP Portfolio

June 12, 2013

Ampersand Adds Cecil Kost as Operating Partner

March 14, 2013

Bioclinica and Corelab Partners Are One

February 25, 2013

Ampersand Capital Partners Expands Management Team

February 5, 2013

Biomedical Structures and Modified Polymer Components Announce Merger

February 4, 2013

Viracor-IBT Laboratories Acquires Assets of Cylex™

January 30, 2013

JLL Partners to Acquire BioClinica and CoreLab Partners

January 14, 2013

ChanTest goes beyond GLP to become first ion channel and GPCR CRO with cGMP testing capability

January 14, 2013

ATS Labs acquires Microcheck, Inc., expands microbiology services to include microbial identification


November 13, 2012

Ampersand Acquires Willow Laboratories

October 17, 2012

Helix Medical Acquires MedVenture Technology

September 24, 2012

Ampersand to Acquire Calloway Laboratories

June 8, 2012

Roadrunner Pharmacy, Inc. Completes Financing for Growth

May 7, 2012

New Biologics Company Launches with Focus on Active Orthopaedic Healing

March 30, 2012

Introducing the World’s Purest Nitinol for Critical Applications

February 2, 2012

MedVenture Technology Opens Minneapolis Office


September 1, 2011

ATS Labs Receives Investment from Ampersand

August 29, 2011

Modified Polymer Components Partners with Ampersand

July 18, 2011

Magellan Biosciences Sells TREK Microbiology Business to Thermo Fisher Scientific

July 12, 2011

Rand Worldwide and Autonomy Form Strategic Partnership

June 10, 2011

Agilux Laboratories Announces Space Expansion to Support Increasing Demand for Its Pharmaceutical and Biotech Services

June 9, 2011

ChanTest Signs Research Collaboration Agreement with the FDA

June 1, 2011

Grifols and Talecris Biotherapeutics Announce the FTC Has Accepted the Consent Agreement for Public Comment

May 2, 2011

Grifols and Talecris Biotherapeutics Announce the Signing of a Consent Agreement with FTC Staff

April 25, 2011

NDC Raises Growth Capital from Ampersand

April 20, 2011

Ampersand Ventures Renamed Ampersand Capital Partners

March 15, 2011

Biomedical Structures Acquires Medical Textile Manufacturer Concordia Medical

February 28, 2011

Blue Sky Biotech Announces New Investment with Ampersand

February 14, 2011

Viracor-IBT Names Paul Sohmer President and CEO


December 14, 2010

Expansion and Partnerships Fuel Record Growth for Biomedical Structures in 2010

September 9, 2010

D. Thomas Oakley Named President and CEO of ChanTest Corporation

August 17, 2010

Rand Worldwide, Inc. and Avatech Solutions, Inc. Merge Business Operations

June 7, 2010

Grifols to Acquire Talecris Biotherapeutics Creating a World Leading Provider of Life-Saving Plasma Protein Therapies

June 3, 2010

ABB agrees to purchase K-TEK

April 14, 2010

PerkinElmer Enters Into Agreement to Acquire Signature Genomic Laboratories, LLC

February 24, 2010

Hiroshi Uchida Named President and CEO of Magellan

February 11, 2010

RadPharm and Medifacts International Merge to Form Leading Independent Core Lab

February 5, 2010

Kortec and Silgan Plastics Sign Agreement to Provide New Multi-Layer Thin-Wall Containers


December 16, 2009

Medifacts International Drives Innovation in Telemedicine for Clinical Trials

November 11, 2009

Dr. John Mills and Joseph Gentile Join Board of Directors of ChanTest Corporation

November 2, 2009

Roche Applied Science Announces CGX Arrays Designed by Signature Genomics for Microarray-based Cytogenetic Analysis

October 28, 2009

Medifacts Reaches Milestone: 10,000 Sites under Management Worldwide

October 8, 2009

IMAGINiT Technologies Now Authorized to Offer Autodesk’s Moldflow Suite of Products

September 30, 2009

Talecris Biotherapeutics Prices Initial Public Offering of Common Stock at $19.00 Per Share

September 22, 2009

Magellan Biosciences Sells its Life Sciences Tools Business to Dionex

September 9, 2009

Agilux Laboratories Hires New Associate Director to Lead In Vitro Admet Services Division

August 31, 2009

ViraCor-IBT Laboratories Launches Comprehensive Influenza and Respiratory Virus Testing Service

August 20, 2009

Signature Genomic Laboratories Named to 2009 Inc. 5000 with Three-Year Sales Growth of 302.9%

July 1, 2009

ViraCor Laboratories and IBT Laboratories Merge to Create Unique Specialty Diagnostics Company

June 29, 2009

Rand Worldwide Now Offering Simens PLM Software to Meet Customer Driven Demands

June 23, 2009

Medifacts Acquires SpaceLabs Healthcare Clinical Trials Services Division

May 7, 2009

Signature Genomic Laboratories detects chromosome abnormalities in individuals with Pallister-Killian syndrome without invasive skin biopsy

May 6, 2009

ChanTest Awarded $4.8 Million Through the Ohio Third Frontier Research and Commercialization Program

April 17, 2009

Medifacts forms Strategic Alliance with Suzuken for Cardiac Safety Services in Japan

March 17, 2009

Magellan to Receive Frost & Sullivan 2009 North American Product Innovation Award; Three-Minute LeadCare(R) II Test Identifies Children with Lead Poisoning

March 12, 2009

Enzo Biochem Acquires Assay Designs, Inc. Further Expanding Life Sciences Operations

February 26, 2009

ChanTest Acquires Applied Cell Sciences

February 12, 2009

Signature microarray covers regions of the genome associated with schizophrenia


September 15, 2008

FDA Grants Approval to Talecris Biotherapeutics for Gamunex® as a Treatment for Neurological Disorder CIDP in the United States

August 29, 2008

Ampersand Ventures leads recapitalization of MedVenture Technology Corporation

August 21, 2008

Signature Genomic Laboratories Named to Inc. 5000

August 12, 2008

Talecris Enters into Definitive Merger Agreement with CSL

July 17, 2008

ChanTest to Highlight the World’s Largest Catalog of Ion Channel-Expressing Cell Lines and Discovery Services at Drug Discovery Technology, Booth 839

July 1, 2008

IBT Laboratories Names Maureen Loftus President and Chief Operating Officer

June 24, 2008

Signature Reports Investment in Company and Appointment of New Chairman of Board of Directors

June 16, 2008

Talecris Biotherapeutics, Inc. Provides Business Update

May 29, 2008

Magellan Biosciences Companies to Feature Automated Products and New Tests for MRSA at the American Society for Microbiology Meeting, Booth 743

May 15, 2008

Agilent Technologies, Signature Genomic Laboratories Announce Long-Term Supply Agreement for Oligo Microarrays

May 08, 2008

FDA Grants Priority Review of Gamunex® as a Treatment for Neurological Disorder CIDP

April 29, 2008

Endeca Named One of Massachusetts’s Fastest Growing Private Company in Boston Business Journal Annual Ranking

March 26, 2008

Significant award further enhances MEDIFACTS’ position as one of the top cardiac safety services providers

January 23, 2008

Endeca Receives Investment from SAP Ventures

January 23, 2008

Intel Capital Invests $10 Million in Endeca

January 10, 2008

Signature microarray covers regions of the genome associated with autism

January 5, 2008

Ampersand Ventures Announces Acquisition of K-TEK Corporation, a Leading Supplier of Level Measurement Instrumentation to the Process Industries


November 28, 2007

RadPharm Announces $10 million Series B Financing, led by Siemens Venture Capital

October 3, 2007

CRI Worldwide Partners with Private Equity Investors to Advance Growth Strategy

August 28, 2007

Magellan Biosciences Names Steven E. Diamond, PhD, Chief Scientific Officer

August 6, 2007

ChanTest Receives Expansion Capital from Ampersand Ventures; Builds World’s Largest Catalog of Ion Channel-Expressing Cell Lines for Use in Drug Discovery and Development

June 18, 2007

Cequent Pharmaceuticals Completes $9 Million Series a Financing With Equity Investment from Novartis Option Fund

May 31, 2007

Endeca Reports Record Q1 Revenue, Plans to Create Hundreds of New Jobs

April 2, 2007

Ortho Organizers, Inc. Introduces New Product Line - Ancor Pro Orthodontic Anchorage System

March 20, 2007

Talecris Initiates Clinical Development Program Evaluating Plasmin for Dissolving Blood Clots and Restoring Blood Flow in Legs


November 28, 2006

Magellan Biosciences Expands Presence in Hospital-Based Laboratory Market with Acquisition of TREK Diagnostic Systems

November 20, 2006

Talecris Biotherapeutics Completes Acquisition of Plasma Collection Centers


August 5, 2005

Ortho Organizers, Inc. Announces Change in Ownership

July 11, 2005

Assay Designs Acquires Stressgen Bioreagents

May 9, 2005

Ampersand Invests in Assay Designs

April 1, 2005

Announcing the Launch of Talecris Biotherapeutics: Combining a Proud History of Patient Care with a Bold New Vision


December 13, 2004

Bayer To Divest its Plasma Products Business To US Investors Cerberus and Ampersand

December 1, 2004

Ampersand Ventures Invests in IBT Reference Laboratory

October 19, 2004

Magellan Biosciences, Inc. Formed Through Combination of ESA and Dynex

May 20, 2004

Ampersand Ventures Acquires Life Science Tools Provider ESA, Inc.

Contact Us

Interested in working with Ampersand? Contact us.